Morgensztern, D., Dols, M. C., Ponce Aix, S., Postmus, P. E., Bennouna, J., Fischer, J. R., . . . Ong, T. J. (2021). nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+). Front Oncol.
Chicago Style CitationMorgensztern, Daniel, et al. "Nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)." Front Oncol 2021.
MLA CitationMorgensztern, Daniel, et al. "Nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)." Front Oncol 2021.
Warning: These citations may not always be 100% accurate.